New hope for blood cancer patients: experimental transplant treatment shows promise

This study is testing whether adding a drug called venetoclax to the standard chemotherapy given before a donor stem cell transplant works better for patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS). The goal is to better prepare the body to accept the donor cells and kill more cancer cells, which could help patients live longer without their disease getting worse. Researchers are comparing two different timing schedules for the drugs to see which one is more effective and safer.